SCHEMBL6167053

SCHEMBL6167053

CC1(c2ccc(Cc3ccccc3)cc2)NC(=S)N(c2ccc(Cl)cc2)C1=O

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 5/20 0.49
ALDH1A1 P00352 3/20 0.44
MAPT P10636 2/20 0.44
ALOX12 P18054 2/20 0.44
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
GAA P10253 1/20 0.42
ELANE P08246 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
SMO Q99835 2/20 0.39
HDAC6 Q9UBN7 1/20 0.39
LMNA P02545 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PGR P06401 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167465 0.86 L3MBTL1 (0.47) CNR1ALDH1A1MAPTALOX12HPGD
SCHEMBL7481341 0.79 CNR1 (0.55) CNR1ALDH1A1MAPTGAAELANE
SCHEMBL6168238 0.77 NPC1 (0.51) ALDH1A1SMN1; SMN2GAAMEN1KMT2A
SCHEMBL6628115 0.77 CNR1 (0.49) CNR1ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL6167711 0.74 CNR1 (0.50) CNR1ALDH1A1GAALMNA
SCHEMBL6625012 0.73 CNR1 (0.46) CNR1ALDH1A1MAPTALOX12HPGD
SCHEMBL6168870 0.73 GAA (0.46) CNR1ALDH1A1MAPTSMN1; SMN2GAA
SCHEMBL6624582 0.72 CNR1 (0.45) CNR1ALDH1A1MAPTMEN1KMT2A
SCHEMBL6169738 0.72 CNR1 (0.43) CNR1ALDH1A1GAAKDM4EMEN1
SCHEMBL6625246 0.71 HTT (0.49) CNR1ALDH1A1MAPTALOX12SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546111-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2005-06-29 EP disclosed
WO-2004031160-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2004-04-15 WO disclosed